moody investors service inc said may upgrade ratings upjohn 400 mln dlrs debt agency said will study effect new products may have upjohn earnings potential moody will also assess effects growth and broader diversification pharmaceutical cash flow will have operating performance moody noted pharmaceuticals and health care markets characterized greater stability cash flow upjohn currently carries senior unsecured long term debt and industrial revenue bonds company prime commercial paper not under review reuter 